91
Participants
Start Date
October 30, 2020
Primary Completion Date
January 30, 2023
Study Completion Date
May 6, 2024
Baricitinib
Participants will take one tablet of study drug per day for 48 weeks, and will be followed up for 48 weeks after study drug treatment has finished. Two-thirds of participants will receive Baricitinib.
Placebo
Participants will take one tablet of study drug per day for 48 weeks, and will be followed up for 48 weeks after study drug treatment has finished. One-third of participants will receive Placebo.
Royal Melbourne Hospital, Parkville
Royal Children's Hospital Melbourne, Parkville
St Vincent's Hospital Melbourne, Fitzroy
Women's and Children's Hospital Adelaide, North Adelaide
Collaborators (1)
Juvenile Diabetes Research Foundation Australia
UNKNOWN
Juvenile Diabetes Research Foundation
OTHER
St Vincent's Institute of Medical Research
OTHER